Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-09-25 Purchase | 2023-09-27 7:46 pm | Acasti Pharma Inc. | ACST | Kavuru Vimal Director 10% Owner | 676,371 | $1.848 | $1,249,934 | 1,735,152 (Indirect) | View |
| 2023-08-31 Purchase | 2023-09-05 3:54 pm | Acasti Pharma Inc. | ACST | Olds Donald Director | 381 | $2.05 | $781 | 1,173 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-05-09 Option Award | 2025-05-13 5:21 pm | N/A 2035-05-09 | Grace Therapeutics Inc. | GRCE | Kottayil George Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2025-05-09 Option Award | 2025-05-13 5:21 pm | N/A 2035-05-09 | Grace Therapeutics Inc. | GRCE | NEUGEBOREN EDWARD Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2025-05-09 Option Award | 2025-05-13 5:21 pm | N/A 2035-05-09 | Grace Therapeutics Inc. | GRCE | DAVIS A BRIAN Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2025-05-09 Option Award | 2025-05-13 5:21 pm | N/A 2035-05-09 | Grace Therapeutics Inc. | GRCE | Kavuru Vimal Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2025-04-14 Option Award | 2025-04-16 8:58 pm | N/A 2035-04-14 | Grace Therapeutics Inc. | GRCE | Kumar Amresh VP Program Management | 30,000 | $0 | 30,000 (Direct) | View |
| 2025-04-14 Option Award | 2025-04-16 8:58 pm | N/A 2035-04-14 | Grace Therapeutics Inc. | GRCE | Macdonald R. Loch Chief Medical Officer | 40,000 | $0 | 40,000 (Direct) | View |
| 2025-04-14 Option Award | 2025-04-16 8:58 pm | N/A 2035-04-14 | Grace Therapeutics Inc. | GRCE | DelAversano Robert J Principal Financial Officer | 20,130 | $0 | 20,130 (Direct) | View |
| 2025-04-14 Option Award | 2025-04-16 8:58 pm | N/A 2035-04-14 | Grace Therapeutics Inc. | GRCE | Kohli Prashant Chief Executive Officer | 225,400 | $0 | 225,400 (Direct) | View |
| 2025-04-14 Option Award | 2025-04-16 8:58 pm | N/A 2035-04-14 | Grace Therapeutics Inc. | GRCE | D'Andrea Carrie VP Clinical Operations | 30,000 | $0 | 30,000 (Direct) | View |
Ownership(A) | 2024-07-11 11:16 am | N/A N/A | Acasti Pharma Inc. | ACST | ADAR1 Capital Management LLC ADAR1 Partners LP 10% Owner | 0 | $0 | 3,141,397 (Indirect) | View |
Ownership | 2024-07-09 8:29 pm | N/A N/A | Acasti Pharma Inc. | ACST | ADAR1 Capital Management LLC ADAR1 Partners LP 10% Owner | 0 | $0 | 959,571 (Indirect) | View |
| 2024-05-06 Option Award(A) | 2024-05-10 4:11 pm | N/A 2034-05-06 | Acasti Pharma Inc. | ACST | D'Andrea Carrie VP Clinical Operations | 19,740 | $0 | 19,740 (Direct) | View |
| 2024-05-06 Option Award(A) | 2024-05-10 4:07 pm | N/A 2034-05-06 | Acasti Pharma Inc. | ACST | Kumar Amresh VP Program Management | 19,740 | $0 | 19,740 (Direct) | View |
| 2024-05-06 Option Award | 2024-05-08 7:19 pm | N/A 2034-05-06 | Acasti Pharma Inc. | ACST | D'Andrea Carrie VP Program Management | 19,740 | $0 | 19,740 (Direct) | View |
| 2024-05-06 Option Award | 2024-05-08 7:19 pm | N/A 2034-05-06 | Acasti Pharma Inc. | ACST | Kumar Amresh VP Clinical Operations | 19,740 | $0 | 19,740 (Direct) | View |
| 2024-05-06 Option Award | 2024-05-08 7:19 pm | N/A 2034-05-06 | Acasti Pharma Inc. | ACST | Macdonald R. Loch Chief Medical Officer | 25,380 | $0 | 25,380 (Direct) | View |
| 2024-05-06 Option Award | 2024-05-08 7:18 pm | N/A 2034-05-06 | Acasti Pharma Inc. | ACST | DelAversano Robert J Principal Financial Officer | 4,500 | $0 | 4,500 (Direct) | View |
| 2024-05-06 Option Award | 2024-05-08 7:18 pm | N/A 2034-05-06 | Acasti Pharma Inc. | ACST | Kohli Prashant Chief Executive Officer | 128,770 | $0 | 128,770 (Direct) | View |
Ownership | 2024-01-08 08:00 am | N/A 2033-12-19 | Acasti Pharma Inc. | ACST | DelAversano Robert J Vice President, Finance | 0 | $0 | 42,000 (Direct) | View |
| 2023-12-19 Option Award | 2023-12-20 4:08 pm | N/A 2033-12-19 | Acasti Pharma Inc. | ACST | Kavuru Vimal Director 10% Owner | 10,000 | $0 | 10,000 (Direct) | View |
| 2023-12-19 Option Award | 2023-12-20 4:08 pm | N/A 2033-12-19 | Acasti Pharma Inc. | ACST | Kottayil George Director | 22,500 | $0 | 22,500 (Direct) | View |
| 2023-12-19 Option Award | 2023-12-20 4:06 pm | N/A 2033-12-19 | Acasti Pharma Inc. | ACST | NEUGEBOREN EDWARD Director | 22,500 | $0 | 22,500 (Direct) | View |
| 2023-12-19 Option Award | 2023-12-20 4:06 pm | N/A 2033-12-19 | Acasti Pharma Inc. | ACST | DAVIS A BRIAN Director | 22,500 | $0 | 22,500 (Direct) | View |
| 2023-12-19 Option Award | 2023-12-20 4:05 pm | N/A 2033-12-19 | Acasti Pharma Inc. | ACST | Kohli Prashant Chief Executive Officer | 41,668 | $0 | 41,668 (Direct) | View |
Ownership | 2023-10-20 12:23 pm | N/A N/A | Acasti Pharma Inc. | ACST | Kottayil George Director | 0 | $0 | 494,698 (Direct) | View |
Ownership | 2023-10-20 12:22 pm | N/A N/A | Acasti Pharma Inc. | ACST | NEUGEBOREN EDWARD Director | 0 | $0 | 37,895 (Direct) | View |
| 2023-07-14 Option Award | 2023-07-18 4:37 pm | N/A 2033-07-14 | Acasti Pharma Inc. | ACST | Derby Michael Director | 12,500 | $0 | 12,500 (Direct) | View |
| 2023-07-14 Option Award | 2023-07-18 4:36 pm | N/A 2033-07-14 | Acasti Pharma Inc. | ACST | Kavuru Vimal Director | 12,500 | $0 | 12,500 (Direct) | View |
| 2023-07-14 Option Award | 2023-07-18 4:36 pm | N/A 2033-07-14 | Acasti Pharma Inc. | ACST | Olds Donald Director | 12,500 | $0 | 12,500 (Direct) | View |
| 2023-07-14 Option Award | 2023-07-18 4:34 pm | N/A 2033-07-14 | Acasti Pharma Inc. | ACST | Macdonald R. Loch Chief Medical Officer | 60,000 | $0 | 60,000 (Direct) | View |
| 2023-07-14 Option Award | 2023-07-18 4:32 pm | N/A 2033-07-14 | Acasti Pharma Inc. | ACST | D'Andrea Carrie VP Clinical Operations | 42,000 | $0 | 42,000 (Direct) | View |
| 2023-07-14 Option Award | 2023-07-18 4:28 pm | N/A 2033-07-14 | Acasti Pharma Inc. | ACST | Kumar Amresh VP Program Management | 42,000 | $0 | 42,000 (Direct) | View |
| 2023-07-14 Option Award | 2023-07-18 4:26 pm | N/A 2033-07-14 | Acasti Pharma Inc. | ACST | Kohli Prashant Chief Executive Officer | 208,334 | $0 | 208,334 (Direct) | View |
Ownership | 2023-05-18 3:57 pm | N/A N/A | Acasti Pharma Inc. | ACST | Kumar Amresh VP Program Management | 0 | $0 | 66,712 (Direct) | View |
| 2022-09-28 Option Award | 2022-09-30 4:21 pm | N/A 2032-09-28 | Acasti Pharma Inc. | ACST | Kavuru Vimal Director | 45,000 | $0 | 45,000 (Direct) | View |